Author Archives: Shane Whitney

Variations in Use of Best Practices for AKI in Three Connecticut Hospitals

New Orleans—There are associations between acute kidney injury (AKI), common in hospitalized settings, and increased length of stay, morbidity, and mortality. There are no specific therapies for AKI; however, recommended guidelines include measures of best practice that could potentially act as the basis of a standardized set of responses to AKI and the development of an AKI report card. Real-world ... Read More »

No Differences in Outcomes of HLA-Incompatible Living Donor Transplantation versus Other Models

New Orleans—Due to the shortage of available kidneys for transplantation, human leukocyte antigen (HLA)-incompatible living donor kidney transplantation is utilized to increase opportunity for sensitized end-stage renal disease patients. There are inconsistencies in outcomes associated with HLA-incompatible kidney transplantation, however. Data in the United States demonstrated better outcomes for patients undergoing HLA-incompatible kidney transplantation compared with HLA-compatible deceased donor transplantation ... Read More »

Self-Monitoring in Management of Hypertension  

Ajay K. Singh, MBBS, FRCP, MBA Brigham and Women’s Hospital and Harvard Medical School Boston, Massachusetts   One of the most common and problematic issues in the care of patients with chronic kidney disease (CKD) is the control of blood pressure. Hypertension is associated with both progression of CKD and with a higher rate of cardiovascular complications such as stroke ... Read More »

From the Field: KNOCKED SENSIPARLESS

Rick Collins Chief Operating Officer Sceptre Management Solutions, Inc.   KNOCKED SENSIPARLESS Patients and providers using Sensipar® (cinacalcet) and Parsabiv™ (etelcalcetide) are experiencing significantly increased financial liability due to inconsistent coverage of the drugs by payers and the dramatic increase in the coinsurance amount assigned by Medicare Part B. The biggest causes of potential lost reimbursement for providers are Medicare ... Read More »

April 2018: Abstract Roundup

CHRONIC KIDNEY DISEASE Nondepressive Psychosocial Factors and Risk of CKD in Black Americans Clinical Journal of the American Society of Nephrology. 2018;13(2):213-222 Researchers led by Joseph Lunyera, MD conducted a study to examine the association of nondepressive psychosocial factors with risk of chronic kidney disease (CKD) among black Americans. Data from the Jackson Heart Study were utilized for the current ... Read More »

April 2018: News Briefs

Two-Day Workshop Presents Data on Use of Earlier Markers of CKD Progression In mid-March, the National Kidney Foundation, in collaboration with the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), concluded a scientific workshop to review the results of a major, multi-year meta-analysis designed to examine the “largest compilation of data ever collected on chronic kidney ... Read More »

Program Streamlining Donor Assessment Process Improves Rate of Living Donor Transplantations

The best outcomes related to patient survival and quality of life for patients with end-stage renal disease (ESRD) are associated with renal transplantation. Greater transplant and patient survival seen in living versus deceased donor transplants; however, efforts to increase rates of living donation need to be balanced with ensuring patient safety via a comprehensive screening process. Prior to 2010 the ... Read More »

Evaluation of RADIANT Community Study Process

Studies of quality improvement interventions at dialysis facilities have shown improvements in end-stage renal disease (ESRD) outcomes and in quality of life of patients with ESRD. However, according to Reem E. Hamoda, MD, and colleagues, those studies focused on effect size in evaluating the success of the intervention, with few data on why the intervention worked or whether the intervention ... Read More »